The Dynamics of Knowledge Accumulation, Regulation and Appropriability in the Pharma-Biotech Sector: Policy Issues

The Dynamics of Knowledge Accumulation, Regulation and Appropriability in the Pharma-Biotech Sector: Policy Issues Book Section How to cite: Orsenigo, Luigi; Dosi, Giovanni and Mazzucato, Mariana (2006). The Dynamics of Knowledge Accumulation, Regulation and Appropriability in the Pharma-Biotech Sector: Policy Issues. In: Dosi, Giovanni and Mazzucato, Mariana eds. Knowledge Accumulation and Industry Evolution. The Case of Pharma-Biotech. Cambridge, UK: Cambridge University Press.

[1]  Josh Lerner,et al.  Stronger Protection or Technological Revolution: What is Behind the Recent Surge in Patenting? , 1997 .

[2]  Steven Klepper,et al.  Technological Extinctions of Industrial Firms: An Inquiry into Their Nature and Causes , 1997 .

[3]  Patrick Llerena,et al.  Science-Technology-Industry Links and the ”European Paradox”: Some Notes on the Dynamics of Scientific and Technological Research in Europe , 2005 .

[4]  W. S. Comanor,et al.  The political economy of the pharmaceutical industry. , 1986, Journal of economic literature.

[5]  R. Nelson.  The market economy, and the scientific commons , 2004 .

[6]  Alfonso Gambardella.  Science and innovation , 1995 .

[7]  J. Lanjouw.  The Introduction of Pharmaceutical Product Patents in India: "Heartless Exploitation of the Poor and Suffering"? , 1997 .

[8]  M. Heller,et al.  Can Patents Deter Innovation? The Anticommons in Biomedical Research , 1998, Science.

[9]  Maureen McKelvey,et al.  Pharmaceuticals Analyzed through the Lens of a Sectoral Innovation System , 2004 .

[10]  K. Arrow.  Economic Welfare and the Allocation of Resources for Invention , 1962 .

[11]  P. David,et al.  Toward a new economics of science , 1994 .

[12]  Louis Galambos,et al.  Pharmaceutical Firms and the Transition to Biotechnology: A Study in Strategic Innovation , 1998, Business History Review.

[13]  Nagesh Kumar,et al.  Technology Generation and Technology Transfers in the World Economy: Recent Trends and Implications for Developing Countries , 1998 .

[14]  P. David.  The Dynamo and the Computer: An Historical Perspective on the Modern Productivity Paradox , 1990 .

[15]  Arvids A. Ziedonis,et al.  The growth of patenting and licensing by U.S. universities: an assessment of the effects of the Bayh–Dole act of 1980 , 2001 .

[16]  C. Freeman.  The ‘National System of Innovation’ in historical perspective , 1995 .

[17]  Lacy Glenn Thomas,et al.  Implicit Industrial Policy: The Triumph of Britain and the Failure of France in Global Pharmaceuticals , 1994 .

[18]  R. Nelson.  The market economy, and the scientific commons , 2004 .

[19]  R. Nelson,et al.  The benefits and costs of strong patent protection: a contribution to the current debate , 1998 .

[20]  G. Dosi,et al.  Technology and the Economy , 2002 .

[21]  Jochen Streb.  Knowledge and competitive advantage , 2004 .

[22]  C. P. Goodman,et al.  The Tacit Dimension , 2003 .

[23]  R. Nelson.  The Simple Economics of Basic Scientific Research , 1959, Journal of Political Economy.

[24]  F. Scherer.  The pharmaceutical industry , 2000 .

[25]  Paul A. David,et al.  Understanding the emergence of 'open science' institutions: functionalist economics in historical context , 2004 .

[26]  Gary P. Pisano,et al.  The Development Factory: Unlocking the Potential of Process Innovation , 1996 .

[27]  Shane M. Greenstein,et al.  Markets for Technology , 2002, IEEE Micro.

[28]  R. Nelson,et al.  On the Complex Economics of Patent Scope , 1990 .

[29]  Paul Nightingale,et al.  The myth of the biotech revolution. , 2004, Trends in biotechnology.